|Articles|January 10, 2012

Symmetry Medical Closes Acquisition of Surgical Instruments Business of Codman & Shurtleff

Symmetry Medical Inc. a leading global source of medical device solutions including surgical instruments, orthopedic implants and sterilization cases and trays, has closed the previously announced acquisition of the surgical instruments business of Codman & Shurtleff, Inc., a Johnson & Johnson company.

Beginning in the first quarter 2012, Symmetry will integrate Codman's line of surgical instruments with the company's current hospital direct business, Specialty Surgical Instrumentation. The combined hospital direct general surgical instruments business will be re-named Symmetry Surgical and is expected to have more than $100 million in annual sales.

Thomas J. Sullivan, president and CEO of Symmetry Medical, says, "Symmetry Surgical provides several strategic benefits for our overall business, including increased revenue diversification, enhanced gross margin, a strategic instruments procurement capability in Tuttlingen, Germany, a strengthened intellectual property portfolio, and innovation driven by access to broader hospital market intelligence in additional surgical specialties. Our resulting offering will be one of the broadest and most respected product portfolios in the $1 billion market for general surgical instruments. This positions us well to continue growing our US market share in the hospital direct business, as well as building on the strong international presence established abroad by the brands acquired from Codman."


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.